In Other News

• AI-Powered Genome Mapping Reveals New Layer of Alzheimer’s Disease Biology

• Residual Disease Test Predicts Merkel Cell Carcinoma Recurrence Earlier Than Antibody Assay

• Portable Rapid Test Aims to Detect Ebola at Point of Care

• AI-Powered Genome Mapping Reveals New Layer of Alzheimer’s Disease Biology

• Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis

• Spectral Flow Cytometry Assay Enhances MRD Detection in Multiple Myeloma

• Collaboration Advances Extracellular Vesicle-Based Tests for Neurodegenerative Diseases

• New Rapid Ebola Antigen Test Detects Infection at Point of Care

• Point-of-Care Molecular Technology Promises Transformative Shift in Oncology

• Preoperative Blood Test Predicts Colorectal Cancer Recurrence and Metastasis

• New Test Delivers Four Prenatal Genetic Screens from One Blood Sample

• Genetic Variations Reveal Mechanisms Behind Sudden Cardiac Death Risk

• Tempus to Acquire Personalis in $1.5 Billion Precision Oncology Deal

• New Marker Helps Detect Aggressive Multiple Myeloma Earlier

• Digital Pathology Tool Predicts Breast Cancer Outcomes and Therapy Response

• Ultrasensitive Blood Test Detects Sjögren’s Signature Years Before Diagnosis

• Multiplex PCR Test Differentiates Four Causes of Ulcerative Skin Lesions

• Blood Test Guides Patient Selection for Radiopharmaceutical Therapy in Prostate Cancer

• Bruker Expands NGS Capabilities for Sepsis and Bloodstream Infections

• Multiplex PCR Test Differentiates Four Causes of Ulcerative Skin Lesions

• AI Bone Marrow Mapping Provides New Tool to Track Blood Cancer Severity

• New Biomarker Helps Guide Combination Therapy for Treatment-Resistant Breast Cancer

• Immune Biomarkers Support Early Risk Stratification in Oral Precancer